Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations	Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast disorder, breast neoplasm, castration-resistant prostate carcinoma, digestive system disorder, digestive system neoplasm, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gastric neoplasm, gonadal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, metastatic prostate carcinoma, neoplasm, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, prostate cancer, prostate disorder, skin disorder, stomach disorder	Active, not recruiting	Phase 2	2026-08-19		NCT04550494

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Cancer Institute (NCI)	3015

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National Cancer Institute Developmental Therapeutics Clinic	Bethesda	United States	28
National Institutes of Health Clinical Center	Bethesda	United States	800
UF Health Cancer Institute - Gainesville	Gainesville	United States	153
University of Oklahoma Health Sciences Center	Oklahoma City	United States	491